Crizotinib in Patients with Tumors with <i>MET</i> Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel, Elad Sharon, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Naoko Takebe, Travis Williams, Jessica J. Croley, Adedayo A. Onitilo, James V. Tricoli, Ju Cheng, Chris Karlovich, Barbara A. Conley, Carlos L. Arteaga, Lyndsay Harris, Peter J. O’Dwyer, David S. Hong, Alice P. Chen, Keith T. Flaherty

Open source

DOI: 10.1158/1078-0432.ccr-25-1247
Published: 2026-01-20
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-1247,
  title = {Crizotinib in Patients with Tumors with
                    <i>MET</i>
                    Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2},
  author = {Niamh Coleman and Zihan Wei and A. John Iafrate and James A. Zwiebel and Elad Sharon and Robert J. Gray and Victoria Wang and Lisa M. McShane and Larry V. Rubinstein and David R. Patton and P. Mickey Williams and Stanley R. Hamilton and Naoko Takebe and Travis Williams and Jessica J. Croley and Adedayo A. Onitilo and James V. Tricoli and Ju Cheng and Chris Karlovich and Barbara A. Conley and Carlos L. Arteaga and Lyndsay Harris and Peter J. O’Dwyer and David S. Hong and Alice P. Chen and Keith T. Flaherty},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-1247},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-1247}
}

RIS

TY  - JOUR
TI  - Crizotinib in Patients with Tumors with
                    <i>MET</i>
                    Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
AU  - Niamh Coleman
AU  - Zihan Wei
AU  - A. John Iafrate
AU  - James A. Zwiebel
AU  - Elad Sharon
AU  - Robert J. Gray
AU  - Victoria Wang
AU  - Lisa M. McShane
AU  - Larry V. Rubinstein
AU  - David R. Patton
AU  - P. Mickey Williams
AU  - Stanley R. Hamilton
AU  - Naoko Takebe
AU  - Travis Williams
AU  - Jessica J. Croley
AU  - Adedayo A. Onitilo
AU  - James V. Tricoli
AU  - Ju Cheng
AU  - Chris Karlovich
AU  - Barbara A. Conley
AU  - Carlos L. Arteaga
AU  - Lyndsay Harris
AU  - Peter J. O’Dwyer
AU  - David S. Hong
AU  - Alice P. Chen
AU  - Keith T. Flaherty
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-25-1247
UR  - https://doi.org/10.1158/1078-0432.ccr-25-1247
ER  -

APA

Coleman, N., Wei, Z., Iafrate, A. J., Zwiebel, J. A., Sharon, E., Gray, R. J., Wang, V., McShane, L. M., Rubinstein, L. V., Patton, D. R., Williams, P. M., Hamilton, S. R., Takebe, N., Williams, T., Croley, J. J., Onitilo, A. A., Tricoli, J. V., Cheng, J., Karlovich, C., Conley, B. A., Arteaga, C. L., Harris, L., O’Dwyer, P. J., Hong, D. S., Chen, A. P., & Flaherty, K. T. (2026). Crizotinib in Patients with Tumors with <i>MET</i> Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-1247

Source records

crossref · retrieved 2026-09-26T07:48:53.824Z